Work

A randomised trial of treatment optimisation in patients with severe asthma using composite type-2 biomarkers to adjust corticosteroid dose versus a symptom/risk-based algorithm

Year: 2020

Type: article

Source: The Lancet Respiratory Medicine

Authors: Liam G. Heaney, John Busby, Catherine E. Hanratty, Ratko Djukanović, Ashley Woodcock, Samantha Walker, Timothy C. Hardman, Joseph R. Arron

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3081031958

FWCI: 0.146

Cites:

Cited by: 1

Related to: 10